Ginette Serrero
10PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jun 24, 2025
8C7: A Fully Human Anti-PTGFRN Monoclonal Antibody-Drug Conjugate Inhibiting Tumour Growth of Mesothelioma and Paediatric Medulloblastoma Cell Lines.Jorge Marquez, Jianping Dong, Binbin Yue
|Jun 26, 2024
Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Expression Correlates With a Metastatic-like Phenotype in Epidermoid Carcinoma, Pediatric Medulloblastoma, and Mesothelioma.Jorge Marquez, Jianping Dong, Jun Hayashi
|May 28, 2022
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients.Alexander Fichte, Angela Neumann, Katrin Weigelt
|Aug 07, 2021
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients.Markus Eckstein, Verena Lieb, Rudolf Jung
|Jun 02, 2021
GP88/PGRN Serum Levels Are Associated with Prognosis for Oral Squamous Cell Carcinoma Patients.Thomas Greither, Tina Steiner, Matthias Bache
|Feb 22, 2021
Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration.Rupa Guha, Binbin Yue, Jianping Dong
Pageof 2
